Company Performance Metrics
Joe R. Sanders: Co-Founder/Chief Marketing and Business Development Officer
Verax Biomedical was founded upon the singular vision of detecting bacterial contamination in cells and tissues intended for transfusion and transplantation. Recognizing that bacteria pose a unique infectious challenge in these life-giving tissues, they realized that novel approaches to detection were called for. While these cellular materials are
routinely tested for viral contaminants, bacteria have posed a long-standing and heretofore poorly addressed challenge. Unlike viruses, bacteria can replicate outside of a living host, meaning they can grow in these cellular matrices during storage prior to transfusion or transplantation. This results in the unique dilemma of an infectious contaminant that can grow from unmeasurably low levels at the time of collection to massive levels at the time of transfusion or transplantation, posing a serious and often fatal risk to their recipient.
